Lineage Cell Therapeutics, Inc. Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31)
Lineage Cell Therapeutics, Inc. (LCTX) reported Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) of $143.00 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-11-12.
Discontinued › Notes › Equity
us-gaap:CumulativeEffectOnRetainedEarningsNetOfTax1 · last filed 2019-11-12
- Lineage Cell Therapeutics, Inc. cumulative effect on retained earnings, net of tax (deprecated 2020-01-31) for the quarter ending 2019-03-31 was $143.00K, a 41.58% increase year-over-year.
- Lineage Cell Therapeutics, Inc. cumulative effect on retained earnings, net of tax (deprecated 2020-01-31) for the quarter ending 2018-06-30 was $1.00K.
- Lineage Cell Therapeutics, Inc. cumulative effect on retained earnings, net of tax (deprecated 2020-01-31) for the quarter ending 2018-03-31 was $101.00K.
| Period end | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) 0 month | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) 3 month | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) 6 month |
|---|---|---|---|
| 2019-03-31 | $143.00K 10-Q · filed 2019-11-12 | ||
| 2019-01-02 | $100.00K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $1.00K 10-Q · filed 2019-11-12 | $102.00K derived: sum of 2 quarters · filed 2019-11-12 | |
| 2018-03-31 | $101.00K 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |